0000000000230344

AUTHOR

Bernhard Przybilla

showing 5 related works from this author

21. Mainzer Allergie-Workshop

2009

03 medical and health sciencesmedicine.medical_specialty0302 clinical medicineOtorhinolaryngologybusiness.industryFamily medicinemedicineImmunology and Allergy030223 otorhinolaryngologybusiness030215 immunologyAllergo Journal
researchProduct

15. Mainzer Allergie-Workshop 2003

2003

030207 dermatology & venereal diseases03 medical and health sciencesmedicine.medical_specialty0302 clinical medicine030228 respiratory systemOtorhinolaryngologybusiness.industryFamily medicinemedicineImmunology and AllergybusinessAllergo Journal
researchProduct

Meat allergy associated with galactosyl‐α‐(1,3)‐galactose (α‐Gal)—Closing diagnostic gaps by anti‐α‐Gal IgE immune profiling

2017

Background Glycoproteins and glycolipids of some mammalian species contain the disaccharide galactosyl-α-(1,3)-galactose (α-Gal). It is known that α-Gal is immunogenic in humans and causes glycan-specific IgG and also IgE responses with clinical relevance. α-Gal is part of the IgE-reactive monoclonal therapeutic antibody cetuximab (CTX) and is associated with delayed anaphylaxis to red meat. In this study, different α-Gal-containing analytes are examined in singleplex and multiplex assays to resolve individual sensitization patterns with IgE against α-Gal. Methods Three serum groups, α-Gal-associated meat allergy (MA) patients, idiopathic anaphylaxis (IA) patients with suspected MA, and non…

AdultMale0301 basic medicineAllergyMeatmedicine.medical_treatmentImmunologyDot blotCross ReactionsImmunoglobulin EArticleYoung Adult03 medical and health sciences0302 clinical medicinemedicineHumansImmunology and AllergyMultiplexAnaphylaxisSensitizationAgedbiologybusiness.industryImmunochemistryGalactoseAllergensImmunoglobulin EMiddle Agedmedicine.diseaseRed Meat030104 developmental biologymedicine.anatomical_structure030228 respiratory systemCase-Control StudiesImmunologyMonoclonalbiology.proteinFemaleThyroglobulinbusinessFood HypersensitivityAnaphylaxisAllergy
researchProduct

Tree-pollen allergy is efficiently treated by short-term immunotherapy (STI) with seven preseasonal injections of molecular standardized allergens.

1998

The efficacy and tolerance of short-term immunotherapy (STI) by seven preseasonal injections of tree-pollen allergens (ALK7 Fruhbluhermischung) was investigated in a double-blind, placebo-controlled, multicenter study with 111 rhinoconjunctivitis patients. Nasal and bronchial symptoms simultaneously analyzed, and nasal symptoms as a single end point, but not the overall score of nasal, bronchial, and conjunctival symptoms, showed a significantly lower increase with STI during birch-pollen exposure (both P=0.033, n=105, Mann-Whitney U-test). However, a selective analysis with patients from centers with high recruitment figures (n> or =10 patients, n=29 STI, n=32 placebo) showed a significant…

AdultMalemedicine.medical_specialtyAllergyTime FactorsAdolescentmedicine.medical_treatmentImmunologyPlaceboImmunoglobulin Emedicine.disease_causeGastroenterologyInjectionsTreesAllergenRibonucleasesDouble-Blind MethodInternal medicineImmunopathologyotorhinolaryngologic diseasesImmunology and AllergyMedicineHumansDesensitization (medicine)Conjunctivitis AllergicSkin TestsEosinophil cationic proteinbiologybusiness.industryRhinitis Allergic SeasonalBlood Proteinsrespiratory systemAllergensEosinophil Granule ProteinsImmunoglobulin EMiddle Agedmedicine.diseaseClinical trialTreatment OutcomeDesensitization ImmunologicImmunoglobulin GImmunologybiology.proteinPollenFemalebusinessAllergy
researchProduct

17. Mainzer Allergie-Workshop

2005

medicine.medical_specialtyOtorhinolaryngologybusiness.industryFamily medicinemedicineImmunology and AllergybusinessAllergo Journal
researchProduct